Skip to main content

Table 2 Correlation analysis between IGF2BP3 and markers of immune cells in TIMER

From: Effects of RNA methylation N6-methyladenosine regulators on malignant progression and prognosis of melanoma

Description Gene markers SKCM
None Purity
Cor P Cor P
CD8 + T cell CD8A − 0.012 0.794 − 0.016 0.738
CD8B − 0.022 0.636 − 0.028 0.553
B cell CD19 − 0.005 0.907 − 0.011 0.810
CD79A − 0.084 0.068 − 0.086 0.066
T cell (general) CD3D − 0.048 0.302 − 0.053 0.254
CD3E − 0.065 0.158 − 0.069 0.140
CD2 − 0.029 0.523 − 0.035 0.456
Monocyte CD86 0.094 0.042 0.094 0.044
CD14 0.028 0.547 0.038 0.421
CD115(CSF1R) 0.065 0.162 0.070 0.133
TAM CCL2 0.063 0.171 0.068 0.146
CD68 0.081 0.078 0.067 0.152
IL10 0.165  < 0.001 0.167  < 0.001
M1 Macrophage INOS(NOS2) − 0.015 0.743 − 0.009 0.844
IRF5 0.020 0.671 0.027 0.571
COX2(PTGS2) 0.148 0.001 0.151 0.001
CD40 0.019 0.676 0.025 0.594
M2 Macrophage CD206(MRC1) 0.165  < 0.001 0.177  < 0.001
CD163 0.180  < 0.001 0.189  < 0.001
VSIG4 0.099 0.031 0.109 0.020
CD200R1 0.147 0.001 0.146 0.002
MS4A4A 0.130 0.005 0.135 0.004
Natural killer cell KIR3DL1 − 0.055 0.230 − 0.063 0.175
KIR3DL2 − 0.080 0.083 − 0.076 0.104
KIR3DL3 − 0.122 0.008 − 0.125 0.008
KIR2DS4 − 0.122 0.008 − 0.084 0.071
  1. Bold values represent significantly different (P < 0.05)
Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us